AxoGen, Inc. target price raised by Truist Securities to $60 from $53
AXGN•Truist Securities raised its target price for AxoGen, Inc. to $60 from $53.
Related News
Microsoft reportedly looks to raise at least $25 billion from US bond sale
MSFT•
Tessera subsidiary Zorronet wins additional antenna order from Israeli defense organization
HLSQ•
Rafael Holdings Q4 net loss narrows on lower costs
RFL•
Tenable Holdings raises target price to $54 from $36
TENB•
FDA clears Eloxx's Exaluren for Phase 2 trial in ADPKD
ELOX•